Literature DB >> 18174772

The treatment of hypertension in the elderly.

Marvin Moser, William C Cushman, Michael G Ziegler.   

Abstract

Following a hypertension symposium in San Francisco in September 2007, an expert panel was convened to discuss the treatment of hypertension in the elderly. Based on recent data, new recommendations may be indicated. The session was moderated by Marvin Moser, MD, Clinical Professor of Medicine at Yale University, New Haven, CT. Participants were William Cushman, MD, Professor of Preventive Medicine and Medicine at the University of Tennessee in Memphis, and Michael Ziegler, MD, Professor of Medicine, University of California at San Diego. The discussion was supported by Novartis Pharmaceuticals and Merck & Company, and each author received an honorarium from Novartis Pharmaceuticals and Merck & Company for time and effort spent participating in the discussion and reviewing the transcript for intellectual content before publication. The authors maintained full control of the discussion and the resulting content of this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174772      PMCID: PMC8110078          DOI: 10.1111/j.1524-6175.2007.07903.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  5 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

2.  Treatment of hypertension in the very elderly: a clinician's point of view.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Sep-Oct       Impact factor: 3.738

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Frans H H Leenen; Chuke E Nwachuku; Henry R Black; William C Cushman; Barry R Davis; Lara M Simpson; Michael H Alderman; Steven A Atlas; Jan N Basile; Aloysius B Cuyjet; Richard Dart; James V Felicetta; Richard H Grimm; L Julian Haywood; Syed Z A Jafri; Michael A Proschan; Udho Thadani; Paul K Whelton; Jackson T Wright
Journal:  Hypertension       Date:  2006-07-24       Impact factor: 10.190

5.  Getting to goal blood pressure: why reserpine deserves a second look.

Authors:  Joshua Barzilay; Richard Grimm; William Cushman; Alain G Bertoni; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

  5 in total
  3 in total

1.  Ten years and counting: the journal of clinical hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

2.  How old is "too old" to start treating high blood pressure?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

3.  Chapter 7: Blood pressure management in elderly persons with CKD ND.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.